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Defects in the apoptotic system are likely to play a role in tumorigenesis. Pancreatic carcinoma cells are extremely resistant to
apoptosis induction by chemotherapy suggesting that the apoptosis machinery is faulty. We investigated the integrity of the
cytochrome c-dependent apoptotic apparatus in 10 human pancreatic carcinoma cell lines. Expression of Apaf-1, caspase-3, -6,
-7, -8 and -9, Hsp-70 and XIAP was detected in all cell lines. The expression levels of Apaf-1 and caspase-8 were
homogenous in all cell lines whereas differences in expression of other caspases were seen. In cytosolic fractions, all
investigated caspases were processed in response to cytochrome c but the extent of processing varied between the cell lines.
No stringent correlation between the amount of processing of caspase-9 and effector caspases was seen. Cytochrome c-
induced effector caspase activity was quantitated by enzyme assay. Especially at low concentrations of added cytochrome c,
this response varied greatly between the cell lines. These data demonstrate that the apoptotic system downstream of the
mitochondria is qualitatively intact in pancreatic carcinoma. They further show that the response to cytochrome c can be
quantitated in a cell-free system and that determinants other than mere expression of apoptotic molecules can regulate
cytochrome c-induced apoptosis.
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Protection against the development of cancer is probably a funda-
mental role of the apoptotic system (Hanahan and Weinberg,
2000). This is, on one hand, supported by the fact that experi-
mental inhibition of apoptosis can contribute to tumorigenesis.
The anti-apoptosis protein Bcl-2, for example, was able to
promote the development of lymphomas in myc-transgenic mice
(Vaux et al, 1988). Loss of the pro-apoptotic protein Bax has also
been shown to lead to an increased appearance of tumours in a
mouse tumour model (Yin et al, 1997). On the other hand, muta-
tions affecting the apoptotic pathway have been found in a
number of tumours. For instance, Bcl-2 is overexpressed from a
chromosomal translocation in follicular lymphoma (Tsujimoto et
al, 1985). Recent work shows that expression of caspase-8 is lost
in a high number of childhood neuroblastomas (Teitz et al, 2000).
Furthermore, the often observed loss of P53 might also contribute
to a loss of sensitivity to apoptotic signals (Clarke et al, 1993;
Lowe et al, 1993). Recently it was shown that cases of human
melanomas have a severely diminished expression of the adapter
protein Apaf-1 and are concomitantly resistant to apoptosis
(Soengas et al, 2001). All of these points of evidence suggest that
apoptosis functions as a defence mechanism against the develop-
ment of cancer.
Recent research has afforded us insight into the apoptosis
pathway. Central to the apoptotic signal transduction is the
caspase family of proteases which are constitutively present in
a cell and become activated during apoptosis. In probably all
cases of apoptosis, so-called effector caspases are active. These
proteases, represented predominantly by caspase-3 (probably
also by caspase-6 and -7), signal apoptosis by activating cata-
bolic enzymes and by a direct digestion of cellular proteins.
The activation of effector caspases is achieved by ‘initiator
caspases’ like caspase-8 and -9 (Earnshaw et al, 1999). Initiator
caspases, in turn, are activated upon adapter-induced oligomer-
isation (Salvesen and Dixit, 1999). A series of reports suggest
that caspase-8 and -9 control independent pathways to effector
caspase-activation. While caspase-8 is activated via cell surface
death-receptors and the adapter FADD/MORT1 (Fas-associated
protein with death domain), caspase-9 is oligomerised and acti-
vated by the adapter Apaf-1 (apoptosis activating factor 1).
Apaf-1-oligomerisation, in turn, is achieved by the binding of
cytochrome c, and cytochrome c-release from mitochondria is
observed in many cases of experimental apoptosis-induction.
In this study we focused on the analysis of cytochrome c-depen-
dent apoptosis apparatus in cell lines derived from human
pancreatic carcinomas. Pancreatic carcinoma is extremely resistant
to therapeutic intervention which probably includes resistance to
apoptosis induction (Warshaw and Fernandez-del Castillo, 1992).
This study was undertaken with the following objectives: First,
we attempted to standardise a cell-free system. Since the induction
of apoptosis by exogenously added substances depends on a great
number of determinants, for instance mechanisms governing
uptake and cellular receptors, we used this cell-free system to
analyse speciﬁcally the caspase-activating capacity of cytochrome
c in cell extracts. Second, chemotherapeutic agents probably act
at least in part to induce apoptosis via cytochrome c-release (Deba-
tin, 2000). The poor response of pancreatic carcinoma to
chemotherapy suggests that the cancer cells are resistant to induc-
tion of apoptosis by these drugs. Likewise, only two out of ﬁve
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mediate) apoptosis upon viral delivery of the fragile histidine
triad (FHIT) gene in vitro indicating a central apoptosis defect at
least in some cases (Dumon et al, 2001). We therefore aimed at
an analysis of the central cytochrome c-driven apoptosis pathway
in cell lines derived from pancreatic carcinomas. The comparison
of a number of cell lines further allowed conclusions whether
expression of Apaf-1 and caspases directly correlates with the cyto-
chrome c-elicited response or whether further regulatory
mechanisms are in place in pancreatic carcinoma.
MATERIALS AND METHODS
Cell lines and culture conditions
Pancreatic carcinoma cell lines AsPC-1 (ATCC, CRL-1682), BxPC-3
(Tan et al, 1986), MiaPaCa-2 (ATCC, CRL-1420), Panc-1 (ATCC,
CRL-1469), PaTu8988t (differentiated) and PaTu8988s (undifferen-
tiated, metastases forming) (these two lines are from the same
patient (Elsasser et al, 1993)) were cultured in Dulbecco’s Modiﬁed
Eagle Medium with 10% FCS; Capan-1 (ATCC, HTB-79), SW850
(Schmiegel et al, 1993) and SW-979 (Kalthoff et al, 1993) in Click’s
RPMI Medium with 10% FCS. Cells were seeded in tissue culture
dishes and cultured at 378C for 3–5 days, harvested in sub-conﬂu-
ent state and lysed as described below.
Extract preparation
Adherent cells were washed in phosphate buffered saline
(Biochrom), trypsinised, centrifuged and resuspended in hypo-
tonic lysis buffer (S100 buffer: 20 mM HEPES-KOH pH 7.5,
10 mM KCl, 1.5 mM MgCl2,1 m M Na-EDTA, 1 mM Na-EGTA)
with a protease inhibitor cocktail (Roche) and 2 mM dithiothreitol
(DTT). For extraction the suspension was incubated for 15 min
on ice. Cells were then lysed by passaging them ﬁve to 20 times
through a 22 gauge needle until about 80 to 100% of the cells
were open as assessed by eosin exclusion. The lysate was then
centrifuged at 10000 g and the supernatant from this step (cyto-
solic fractions) was immediately frozen in aliquots at 7708C.
Before use extracts were thawed on ice and total protein content
was estimated by measuring absorption at 280 nm in comparison
to a BSA standard.
Caspase activation by cytochrome c
Caspase activation was assessed after incubation of the cytosolic
extracts in S100 buffer with deﬁned amounts of total protein with
various concentrations of bovine heart cytochrome c (Sigma) in the
presence or absence of 1 mM dATP and in presence of 1 mM DTT.
Effector caspase activity was determined after 1 h of incubation at
378C by measuring the extent of cleavage of the synthetic ﬂuoro-
genic substrate acetyl-aspartate-glutamate-valin-aspartate-7-amino-
4-methyl-coumarin (Ac-DEVD-AMC) (Bachem; ﬂuorescence of
free AMC: excitation 360 nm, emission 460 nm) in a Millipore
Cytoﬂuor 2350 Fluorescence Measurement System at a series of
time points after addition of substrate as described (Linsinger et
al, 1999). A linear regression was established of the linear increase
of the ﬂuorescence during the ﬁrst 10–20 min after addition of
Ac-DEVD-AMC. The regression coefﬁcient was deﬁned as effector
caspase activity.
Western blotting
Expression of apoptosis-relevant proteins and processing of pro-
caspases was measured by Western blotting. Samples were
subjected to SDS–PAGE, transferred to a nitrocellulose
membrane and proteins were detected using speciﬁc antibodies
and horseradish peroxidase conjugated secondary antibodies
(antibodies were from Pharmingen (anti-caspase-3, caspase-6,
caspase-7, caspase-9 and Apaf-1), Upstate Biotechnologies
(anti-caspase-8), Stressgen (anti-Hsp-70 (heat shock protein
70)) and R&D Systems (XIAP (X-linked inhibitor of apoptosis
protein))).
RESULTS
Pancreatic carcinomas vary in expression of components of
the apoptotic system and in the propensity to process
caspases in response to cytochrome c
The central signal transduction complex of cytochrome c-depen-
dent apoptosis encompasses the proteins Apaf-1, caspase-9,
caspase-3 and perhaps further components such as Hsp-70 and
XIAP (Beere et al, 2000; Saleh et al, 2000; Bratton et al, 2001).
We tested expression of these components by Western blotting.
Processing of caspases upon incubation with dATP/cytochrome c
was further investigated. For most cell lines, between two and four
different preparations of extract were tested. Figure 1 details exam-
ples of the experiments.
The expression of caspase-8 and Apaf-1 was homogenous
across all cell lines tested (Figure 1A,C bottom and data
not shown). All the caspases investigated were detectable in
all cell lines although there was variation in expression level
between the lines. The expression levels of caspase-3, -6, -7
and -9 were comparable in all cell lines (Figure 1B,C and
data not shown). Relatively low expression of caspase-6 was
observed in the cell lines Capan-1 and MiaPaCa-2 (Figure
1C and data not shown).
To assess the capacity for caspase processing, cell extracts were
subjected to Western blotting upon incubation at 378C in the
presence of dATP and either without or with cytochrome c. Cyto-
chrome c activates apoptotic signaling by binding to Apaf-1 which
in turn forms (in the presence of dATP) high molecular weight
complexes consisting of several molecules of Apaf-1, caspase-9
and caspase-3. In the course of this association, ﬁrst caspase-9
and later caspase-3 is activated (Cain et al, 1999; Rodriguez and
Lazebnik, 1999; Zou et al, 1999; Bratton et al, 2001). Examples
of results from these experiments are given in Figure 1B,C. A
summary of the semi-quantitative evaluation of the results is given
in Table 1.
Intriguingly, despite the relatively even expression levels
between the cell lines, we found pronounced differences in cyto-
chrome c-induced caspase-processing. Processing of the apical
caspase caspase-9 was seen in all cell lines, strongest in the lines
AsPC-1 and SW850 (Figure 1B). In extracts only from AsPC-1
cells bands were detected by Western blotting which corre-
sponded to even smaller proteins than the 35 and 37 kD
processed forms described (Jiang and Wang, 2000); in the other
cell lines exclusively the known processing products were seen.
As far as we are aware, such smaller processing bands have
not been described before; they appear to result from further
proteolytic processing, possibly related to caspase-activity. It is
remarkable that – although saturating concentrations of cyto-
chrome c were used in these experiments (see below) –
differences in the activation of caspase-9 were apparent between
the cell lines. This indicates that expression of the core proteins
Apaf-1 and caspase-9 is not the only determinant of this activa-
tion.
The processing of caspase-3 should in the simplest case be
directly correlated with the processing of caspase-9. We did,
however, not ﬁnd the expected stringent correlation. While in
AsPC-1-extracts the caspase-3-processing paralleled the strong
caspase-9-processing, MiaPaCa-2 and SW850 showed only moder-
ate processing of caspase-3 in the presence of stronger caspase-9-
activation indicating that further regulatory factors of this step
exist. In support of this view, the line DanG showed only weak
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Figures 1B,C and 3).
Caspase-6 and caspase-7 are ranked as effector caspases which
might fulﬁll independent functions in cell death: they are activated
in response to caspase-9-activation although it is not entirely clear
whether directly or upon activation of caspase-3 (Slee et al, 1999;
Vier et al, 2000). Caspase-6 was processed upon addition of cyto-
chrome c although to different extents (Figure 1C). The same was
the case for caspase-7 (Figure 1B).
Caspase-8 is normally activated upon death receptor signalling,
following recruitment to the plasma membrane (Kischkel et al,
1995). It can, however, also be activated secondarily to effector
caspase-activation during drug-induced apoptosis but the signiﬁ-
cance of this activation is unknown (Ferrari et al, 1998). In all
lines a slight processing of caspase-8 upon cytochrome c-addition
was detected. This processing correlated with the processing of
caspase-3 and is likely to be the result of ‘retrograde’ activation
of caspase-8 by caspase-3 (Figure 1C and see below).
Induction of effector caspase-activity by cytochrome c
Effector caspases will lead to apoptosis by their proteolytic activity
cleaving after the tetrapeptide DEVD. This activity is probably
mainly conveyed by caspase-3, to a lesser extent by caspase-7
(Thornberry et al, 1997; Earnshaw et al, 1999). The generation
of this DEVD-cleaving (effector caspase) activity was measured
in extracts from the pancreatic carcinoma cell lines upon incuba-
tion with cytochrome c. For a quantitative assessment of the
activity, DEVD-cleaving activity was calculated by linear regression
analysis as the regression coefﬁcient of free AMC ﬂuorescence
under conditions of substrate saturation. Titration of the concen-
tration of cytochrome c showed that concentrations above about
25 mgm l
71 yielded maximal caspase-activation (‘saturating
concentration’; data not shown). Caspase-activity was consecu-
tively compared between the cell lines at saturating
concentrations of cytochrome c (50 mgm l
71) and at one lower
concentration (1 mgm l
71).
At saturating concentrations of cytochrome c extracts of all
tested pancreatic carcinomas showed increased effector caspase
activity compared with the control without cytochrome c. The
DEVD-AMC-cleaving activity depended on the amount of cyto-
chrome c added and this sensitivity towards cytochrome c was
greatly different between the cell lines. Differences in this response
were seen at saturating concentrations (Figure 2D) but were even
more pronounced at low concentrations of cytochrome c (Figure
2C). Extracts from the cell line SW850 (Figure 2B,C) were almost
completely refractory to low cytochrome c-concentrations while
AsPC-1 (Figure 2A,C) and PaTu8988t-extracts (Figure 2C) showed
already almost maximal caspase-activation. The other lines were
placed between these two extremes, again with signiﬁcant differ-
ences in sensitivity. A summary of the experiments with all lines
is shown in Figure 2C,D.
Since this response did not correlate with expression of either
Apaf-1, caspase-9 or caspase-3 (compare e.g. AsPC1, SW850 and
MiaPaCa-2 as to their expression (Figure 1) and the elicited activ-
ity (Figure 2 and Table 1)), these results suggest that further
determinants exist in these cells which govern caspase activation
by cytochrome c.
Cytochrome c-induced effector caspase activity correlates
with the degree of caspase-3 processing
Effector caspase activation measured as DEVD-AMC cleavage was
in further experiments correlated with the processing of caspase-3.
For instance, in AsPC-1 extracts (which showed strong DEVD-
AMC cleaving activity when incubated with cytochrome c), strong
processing of caspase-3 was detected (Figure 3) while only poor
processing of this caspase occurred in extracts from the cell lines
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Figure 1 Expression of core components of apoptosis in pancreatic car-
cinoma cell lines. Expression of Apaf-1, of caspase-3, -6, -7, -8, -9 and cy-
tochrome c-induced processing of caspase-3, -6, -7, -8 and -9 were
assessed by Western blotting. Extracts (200 mg total protein) were sub-
jected to SDS–PAGE either directly (A) or after 1 h of incubation at
378C (20 mg ml
71 in B and C;1 0ml were loaded for Western blot ana-
lysis) in the absence or presence of cytochrome c (50 mgm l
71) as indi-
cated. Western blot analysis was performed using antibodies speciﬁc for
Apaf-1 (A), caspase-9 (B, top), -7 (B, bottom), -3 (C, top), -6 (C, middle)
and -8 (C, bottom). Open arrowheads show the pro-caspase, ﬁlled arrow-
heads the processed forms of caspases. Cyt c: cytochrome c; *Unusual pro-
cessed form of caspase-9 in AsPC-1. We were unable to detect processed
caspase-6 with the antibody used since this antibody showed strong cross-
reactivity with cytochrome c (which ran at about the same molecular size,
not shown).
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levels of effector caspase activity measured.
Caspase-3 activity is probably responsible for at least a majority
of the observed morphological and functional alterations during
apoptosis, for instance the well-characterized nuclear changes
(although apoptosis proceeds normally even in the absence of a
nucleus (Jacobson et al, 1994)). We established that staurosporine
was able to induce a varying degree of nuclear degradation
(‘laddering’) in the four cell lines investigated (AsPC-1,
MiaPaCa-2, SW850 and BxPC-3) indicating that this part of the
apoptotic machinery is also intact (data not shown).
Expression of the potential regulators of cytochrome-c-
dependent caspase-activation, Hsp-70 and XIAP
Heat shock protein 70 (Hsp70) (Beere et al, 2000; Saleh et al, 2000)
and the X-linked inhibitor of apoptosis protein (XIAP) (Deveraux
et al, 1997) were shown to be able to inhibit cytochrome c-depen-
dent caspase-activation; XIAP furthermore co-elutes with the active
Apaf-1/caspase-9/caspase-3-complex (Bratton et al, 2001). As
shown in Figure 4, all cell lines expressed these two proteins to a
similar level. The minor differences detected did not correlate with
the sensitivity towards cytochrome c. Therefore, a regulation of
cytochrome c-induced caspase-activation by these two factors is
not evident in human pancreatic carcinoma.
DISCUSSION
We investigated the central signal transduction of apoptosis in cell
extracts from pancreatic carcinoma cell lines. The results show that
all known essential components of this pathway were expressed in
all cell lines. There were, however, differences between the cell lines
in effector caspase-processing and cytochrome c-induced activity.
The comparison between a number of cell lines further allows
conclusions about regulatory steps in the cell death pathway.
Since the discovery that free cytosolic cytochrome c can activate
caspases (Liu et al, 1996), numerous examples have been reported
demonstrating that cytochrome c released from mitochondria can
trigger caspase-activation in cytosolic extracts. To our knowledge,
however, no system has been established which would allow the
quantiﬁcation of caspase-activation in cell extracts. Our results
show that it is indeed possible to obtain reproducible results which
permit the assessment of a relative sensitivity towards cytosolic
cytochrome c.
All pancreatic tumour cell lines investigated expressed all the
known core components, although not in all cases to the same
levels. A number of recent studies have investigated the expression
of these proteins in various types of tumour cells and reported
differences, for instance loss of caspase-8-expression in a number
of neuroblastomas and of Apaf-1 in melanomas (Teitz et al,
2000; Soengas et al, 2001). In other tumour types such as acute
leukaemia these proteins appear to be generally expressed but at
widely different levels without a clear correlation with the response
to chemotherapy (Svingen et al, 2000). The expression of some
components in the pancreatic cell lines was found to be remarkably
similar, especially of caspase-8 and Apaf-1 but also, with some
small variations, of caspase-9. The strongest variation was found
for caspase-6, second for caspase-3.
The available data regarding expression of caspases in tissue are
limited since most studies have been carried out on tumour cell
lines. In the case of the pancreas, it has been suggested that expres-
sion of caspase-1 is elevated in adenocarcinoma as compared to
normal pancreas tissue (Gansauge et al, 1998). Caspase-1 is,
however, usually most likely not involved in cell death and there-
fore an unlikely regulator of apoptosis. Another study found a
higher level of caspase-3 mRNA in pancreatic carcinoma than in
normal tissue (Satoh et al, 2000). How this elevated gene expres-
sion could be correlated with malignancy is unclear. We
compared expression levels in the pancreatic carcinoma cell lines
with the expression of the well-studied T-cell line Jurkat. Expres-
sion of caspases in Jurkat cells is comparable to the level seen in
normal human T-cells and was found to be in the same range as
in pancreatic carcinomas (data not shown). Changes in expression
of caspases are therefore unlikely to contribute to tumorigenesis of
pancreatic carcinomas.
The expression of Apaf-1 and caspase-8 was surprisingly even in
all tested cell lines. Little is known about the regulation of expres-
sion of these proteins; our data suggest that the regulation of
expression of some caspases (especially caspase-8 and -9) is more
stable than and therefore regulated differently from others such
as caspase-3 and -6. The investigation of a number of cell lines
enabled us to compare the events of caspase-expression, proteolytic
activation and activity and assess correlations (or lack of correla-
tion) within these entities. The simplest perception is that
cytochrome c allows binding of dATP to Apaf-1 which in turn
permits the formation of a complex containing Apaf-1, caspase-9
and caspase-3 (Cain et al, 1999). Formation of this complex leads
to the activation of caspase-9 and caspase-3. This process can
indeed be re-played using the puriﬁed components (Jiang and
Wang, 2000). However, analysis of extracts from pancreatic tumour
cell lines shows that this process is not as straightforward as these
data suggest. We did observe a correlation between the proteolytic
activation of caspase-3/caspase-7 and the detectable DEVD-cleaving
activity. There was, however, no clear correlation between the
measured DEVD-cleaving activity and the level of expression of
either caspase-3, -7 or -9. Furthermore, the amount of processing
of caspase-9 was not stringently correlated with the processing of
caspase-3. Finally, the response to the addition of cytochrome c
(as measured as effector caspase-processing and DEVD-cleaving
activity) varied between the different cell lines (especially at
1 mgm l
71 cytochrome c) despite the relatively even expression of
Apaf-1 and caspase-9. These results imply that regulatory steps
exist other than mere expression which govern this activation.
Expression of two candidate regulator proteins, Hsp70 and XIAP,
did not provide an explanation: cell lines with poor response to
cytochrome c did not express higher levels of these inhibitory
proteins than good responders. It is therefore likely, that further,
unknown regulatory components of the cell death pathway exist
which are able to impact at this central point of apoptosis trans-
duction.
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Table 1 Semi-quantitative assessment of cytochrome c-induced caspase-processing
AsPC-1 BxPC-3 Capan-1 DanG MiaPaCa-2 Panc-1 SW850 SW-979 PaTu8988t PaTu8988s
Caspase-3 ++/+++ ++ ++ ++/+++ + 7/+ + + ++ +/++
Caspase-6 +/++ + (+)/+ + + + +/++ ++ n.d. +
Caspase-7 +++ ++ +/++ ++ +/++ +/++ +/++ +/++ ++ ++
Caspase-8 + + (+) + + (+) + + n.d. +
Caspase-9 ++ + + + +/++ + ++ + ++ +
Cell extracts were incubated in the presence of dATP and cytochrome c (50 mgm l
71) as described in Figure 2. Caspase-processing was assessed by Western
blotting and semi-quantitative values were derived from between 2–4 independent extracts from the cell lines shown. n.d., not done.
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British Journal of Cancer (2002) 86(6), 893–898 ã 2002 Cancer Research UKIn summary, these data attest the general integrity of the
apoptosis pathway downstream of mitochondria in all 10 inves-
tigated cell lines from human pancreatic carcinoma. The
relatively poor response to cytochrome c in some lines (such
as SW850 or Panc-1) might have contributed to tumour devel-
opment, taking into account that tumour biology probably
depends on a subtle balance of apoptosis-inducing and -inhibit-
ing factors in vivo. It is, however, unlikely from our data that
defects in the apoptotic core-system are the main reason for
the apoptosis-resistance of these cells. The investigated cell lines
have various genetic make-ups: for instance, BxPC-3 is unusual
in that it contains an intact P53 protein, and SW850 and SW-
979 have a normal K-ras protein; the similar pattern of reaction
in all lines indicates that the frequently observed mutations in
these oncogenes do not necessarily lead to alterations in the
central apoptosis pathway. Apoptosis resistance might be corre-
lated to changes of upstream apoptosis regulators such as the
Bcl-2-family of proteins. It is, however, important to note that
future attempts at reversing an apoptosis resistance in pancreatic
carcinomas should focus on such upstream parts of the apoptosis
pathway and that therapeutical correction of the downstream
parts is probably not required.
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Figure 2 Induction of effector caspase activity by cytochrome c. Cell ex-
tracts (20 mg ml
71 total protein) were incubated with 1 mM dATP for 1 h
at 378C in the absence or presence of cytochrome c; then the ﬂuorogenic
substrate DEVD-AMC was added. The release of ﬂuorescent AMC was
monitored over a period of 100 min. (A), extract from AsPC-1, (B), ex-
tract from SW850. Curves show the activity generated in the absence of
cytochrome c (ﬁlled squares) and in the presence of 1 mgm l
71 (open
squares) or 50 mgm l
71 (open triangles) of cytochrome c.( C,D) Three in-
dependently prepared extracts from each cell line were incubated for 1 h
at 378C (20 mg ml
71 total protein) in the presence of either 1 mgm l
71
(C)o r5 0mgm l
71 (D) cytochrome c. Results are presented as the mean
and standard error of the mean of the regression coefﬁcient determined as
described in Materials and Methods.
58 —
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Figure 4 Expression of Hsp70 and XIAP in pancreatic carcinoma cell
lines. Samples of extracts from the indicated cell lines (200 mg total pro-
tein/lane) were subjected to Western blotting with antibodies speciﬁc for
XIAP (top) or Hsp70 (bottom).
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Figure 3 Processingofcaspase-3bytwoconcentrationsofcytochromec.
ExtractsfromthecelllinesAsPC-1,PaTu8988t,MiaPaCa-2andSW850were
incubated in the absence or the presence of either 1 or 50 mgm l
71 cyto-
chrome c as described above. After 1 h, samples were taken and subjected
to Western blotting with antibodies speciﬁc forcaspase-3.
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